6.50
Finanzdaten der Achieve Life Sciences Inc-Aktie (ACHV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Costs And Expenses |
75.78%
18.39
|
10.46 | 14.73 | 14.69 | 12.56 |
| Depreciation and Amortization |
1.75%
0.058
|
0.057 | 0.057 | 0.054 | 0.055 |
| Nonoperating Income/Loss |
19,211%
-56.38
|
0.295 | 0.069 | 0.251 | -0.155 |
| Net Income/Loss |
635.34%
-74.77
|
-10.17 | -14.66 | -14.44 | -12.72 |
| Basic Average Shares |
75.17%
93.51
|
53.38 | - | 51.02 | 34.69 |
| Diluted Average Shares |
75.17%
93.51
|
53.38 | - | 51.02 | 34.69 |
| Basic Earnings Per Share |
321.05%
-0.80
|
-0.19 | - | -0.28 | -0.37 |
| Diluted Earnings Per Share |
321.05%
-0.80
|
-0.19 | - | -0.28 | -0.37 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):